Is 100mg Trazodone a Lot? Sleep vs. Depression

A 100 mg dose of trazodone sits at the ceiling of what most clinicians consider “low dose” for sleep but far below what is needed to treat depression. That single number lands in very different territory depending on why you’re taking it. For insomnia, 25 to 100 mg at bedtime is the standard range, so 100 mg is on the higher end of a sleep dose. For major depression, effective doses typically start at 150 mg per day and can climb as high as 600 mg, making 100 mg barely therapeutic. The gap between these two uses is wide enough that understanding where your dose falls matters for expectations, side effects, and how long you might stay on the drug.

Why the Same Drug Works at Such Different Doses

Trazodone hits several receptor systems in your brain, and the balance shifts as the dose climbs. At low doses, it primarily blocks serotonin 2A receptors, histamine H1 receptors, and alpha-1 adrenergic receptors. That combination is what makes you drowsy: blocking histamine receptors is the same mechanism behind over-the-counter sleep aids like diphenhydramine, while blocking serotonin 2A receptors promotes deeper stages of sleep. At 25 to 100 mg, these sedating effects dominate with little meaningful antidepressant action.¹

To get genuine antidepressant effects, you need higher doses, generally 150 to 300 mg per day or more, where trazodone begins meaningfully inhibiting serotonin reuptake on top of its receptor-blocking activity.² This is an unusual profile among antidepressants. Most SSRIs work at similar doses for both anxiety and depression. With trazodone, the sleep dose and the depression dose are essentially different drugs in terms of what receptors are being engaged.

So if you’re taking 100 mg specifically for sleep, you’re at a reasonable dose doing what trazodone is most commonly used for. If someone handed you 100 mg expecting it to treat clinical depression on its own, the evidence says that’s not enough.

How Trazodone Became the Most Prescribed Sleep Drug in the Country

Trazodone was approved by the FDA in 1981 as an antidepressant. It was never approved as a sleep medication. Yet by 2019, roughly three-quarters of all trazodone prescriptions in the United States were written for insomnia and other sleep disorders, not depression. That year, about 20 million trazodone prescriptions were for off-label uses, and trazodone was the single most frequently prescribed drug for insomnia, edging out even zolpidem (Ambien).³

This happened partly because the alternatives carry baggage. Benzodiazepines are effective but come with dependence, tolerance, and cognitive concerns. The newer Z-drugs like zolpidem still carry some of those risks and occasionally produce strange behaviors like sleepwalking. Trazodone, meanwhile, has low abuse potential and doesn’t produce the kind of tolerance that makes people need ever-higher doses. For prescribers looking for something to help a patient sleep without starting a controlled substance, trazodone became the path of least resistance. Earlier research focused on using it at higher doses for insomnia in depressed patients, but since the 2000s, low-dose trazodone has expanded to treating sleep problems in non-depressed people as well.⁴

What 100 mg Actually Does to Your Sleep

The clinical evidence for trazodone as a sleep aid is decent but not overwhelming. A meta-analysis of randomized controlled trials found that trazodone added about 40 minutes of total sleep time compared to placebo and cut the time it took people to fall into sustained sleep by roughly 19 minutes. It also increased the proportion of deep slow-wave sleep (the most restorative stage) and significantly reduced nighttime awakenings.⁵ Those are meaningful improvements for someone lying awake at 2 a.m.

Interestingly, separate meta-analytic work found that while trazodone clearly helps with sleep maintenance by cutting down early awakenings and improving how people perceive their sleep quality, some objective measures like overall sleep efficiency didn’t always reach statistical significance.⁶ In other words, people taking trazodone consistently say they sleep better, and the measured number of awakenings backs that up, but the total percentage of time spent asleep once in bed doesn’t always change as dramatically as you’d expect on a sleep study readout. Earlier work showed that trazodone halved the frequency of arousals interrupting sleep and boosted slow-wave sleep, though it did reduce REM sleep somewhat.⁷

For most people using trazodone at 50 to 100 mg, the practical effect is fewer middle-of-the-night wake-ups, a faster drift into sleep, and a subjective sense of more refreshing rest. It’s not a knockout drug in the way a benzodiazepine is. If you’re expecting the feeling of being chemically forced to sleep, trazodone at these doses will probably seem mild.

What 100 mg Cannot Do for Depression

If you’re taking 100 mg of trazodone and hoping it addresses clinical depression, the dose is likely too low to get you there on its own. Clinical trials comparing trazodone to other antidepressants used doses in the 150 to 300 mg per day range, and at those levels, trazodone showed comparable effectiveness to tricyclic antidepressants, SSRIs, and SNRIs.⁸ Studies in older adults with major depression found that trazodone at therapeutic doses outperformed placebo and matched drugs like fluoxetine and imipramine.⁹

That said, 100 mg is not useless in the context of depression treatment. Trazodone is sometimes prescribed at lower doses alongside another antidepressant, often an SSRI, specifically because the SSRI treats the depression while trazodone at 50 to 100 mg handles the insomnia that SSRIs frequently worsen. A meta-analysis found that adding trazodone to antidepressant treatment significantly improved both sleep quality and depression severity scores.¹⁰ So your doctor might prescribe 100 mg of trazodone as part of a broader strategy for depression, but it’s the supporting player, not the lead.

Side Effects at the 100 mg Level

The side effect profile at 100 mg mostly reflects the drug’s sedating mechanisms. The most commonly reported effects include daytime drowsiness, headache, nausea, and dizziness.¹¹ Morning grogginess is the complaint you’ll hear most often, especially when people first start or when the dose goes above 50 mg. Taking it shortly before bed rather than earlier in the evening can help, and food slightly increases absorption but also delays the peak by about an hour, which is worth knowing if you’re timing it precisely.¹²

One side effect that deserves special attention is orthostatic hypotension, the dizzy-when-you-stand-up feeling caused by a drop in blood pressure. Trazodone blocks alpha-1 adrenergic receptors, and that effect doesn’t need high doses to kick in. A study of older adults with high blood pressure found that trazodone users had a significantly larger blood pressure drop immediately after standing compared to non-users.¹³ This is especially relevant for nighttime bathroom trips: you wake up groggy, stand quickly, and your blood pressure hasn’t caught up. A review in hypertension research flagged trazodone alongside other drugs that are easily overlooked as contributors to orthostatic hypotension.¹⁴

The meta-analysis data on adverse effects in depressed patients showed that trazodone was associated with a substantially higher odds of blurred vision, excessive sleepiness during the day, and sedation compared to placebo.¹⁰ These are dose-dependent to some degree, so people at 100 mg are more likely to experience them than those at 25 or 50 mg, but less likely than those on antidepressant-range doses. Priapism, the rare but serious side effect involving a prolonged erection, is something you should be aware of at any dose, though it’s uncommon enough that it shouldn’t be a primary concern for most people.

The Fall Risk Problem in Older Adults

If you’re over 65 or caring for someone who is, the fall risk conversation around trazodone is worth having separately. There has been a widespread assumption that trazodone is safer than benzodiazepines for older adults who need help sleeping, partly because it’s not a controlled substance and doesn’t carry the same dependence profile. The data on falls complicates that assumption.

A matched-cohort study in nursing home residents found that new use of low-dose trazodone carried a fall-related injury risk that was no safer than new use of benzodiazepines.¹⁵ A broader analysis of older adults with insomnia confirmed that both benzodiazepines and trazodone were associated with the greatest fall risk among the sleep medications studied.¹⁶ And in older adults with dementia specifically, trazodone showed fall and fracture rates similar to those of atypical antipsychotics, prompting researchers to conclude that trazodone is not a uniformly safer alternative in this population.¹⁷

The orthostatic hypotension issue discussed earlier is a major driver here. A 75-year-old getting up to use the bathroom at 3 a.m. while under the combined sedative and blood-pressure-lowering effects of trazodone is a recipe for a fall. This doesn’t mean trazodone is never appropriate for older adults, but the reflexive assumption that it’s the gentle option needs to be questioned.

Combining Trazodone With Other Medications

Because trazodone at 100 mg is so commonly prescribed as an add-on to another medication (often an SSRI for depression or anxiety), the interaction profile matters. The most serious risk is serotonin syndrome, a rare but potentially life-threatening condition caused by too much serotonin activity. A case report detailed a 25-year-old man who developed serotonin syndrome when trazodone was rapidly titrated alongside sertraline and risperidone.¹⁸ The keyword there is “rapid titration.” Combining trazodone with an SSRI is done routinely and is generally safe when doses are increased gradually and monitored. But stacking multiple serotonin-affecting drugs at once, or escalating them quickly, raises the risk.

Trazodone is broken down primarily by the liver enzyme CYP3A4, and during that process it produces an active metabolite called mCPP, which has its own serotonergic effects. That metabolite is then inactivated by a second enzyme, CYP2D6.¹⁹ Drugs that inhibit either of these enzymes can change how much trazodone and its metabolite accumulate in your body. Common CYP3A4 inhibitors include certain antifungals, macrolide antibiotics, and grapefruit juice. If you’re on one of these alongside trazodone, you may effectively be getting a higher dose than what’s written on your pill bottle.

What Happens When You Stop

One of trazodone’s selling points is that it’s generally easier to stop than benzodiazepines. But “easier” doesn’t mean “no withdrawal at all.” Case reports have documented withdrawal symptoms even when trazodone was tapered gradually from therapeutic (antidepressant-range) doses. The proposed mechanism involves a rebound in the noradrenergic system after the serotonergic effects of trazodone and its metabolite are removed, combined with the relatively short half-lives of both compounds.²⁰

At 100 mg for sleep, the discontinuation picture is generally milder than at antidepressant doses, but you should still taper rather than stop abruptly, especially if you’ve been on it for more than a few weeks. Withdrawal symptoms can include rebound insomnia (your sleep problems temporarily return worse than before), anxiety, irritability, and in some cases mild physical symptoms like sweating. The rebound in sleep architecture is worth knowing about: after stopping trazodone, REM sleep tends to bounce above baseline levels temporarily, which can mean more vivid or disturbing dreams for a few nights.

Trazodone for Sleep After Alcohol Detoxification

One population where trazodone at roughly 100 mg has been specifically studied is people recovering from alcohol use. Sleep disturbance is one of the most common complaints during and after alcohol detox, and it’s a known driver of relapse. A randomized trial tested low-dose trazodone (starting at 50 mg, titrated up to 150 mg) in 173 patients after alcohol detoxification. Participants averaged about two 50 mg tablets per day, landing most of them close to the 100 mg range.²¹ Trazodone’s low abuse potential makes it particularly appealing in this context, since prescribing a benzodiazepine or a Z-drug to someone in early recovery carries obvious risks.

How Trazodone Compares to Other Sleep Medications

If you’re wondering whether 100 mg of trazodone is a lot compared to what other drugs offer, the comparison is useful. Trazodone versus doxepin (another antidepressant repurposed for sleep at low doses) was studied in psychiatric inpatients, with no statistically significant difference in treatment failure rates between the two.²² Doxepin is FDA-approved for insomnia at very low doses (3 to 6 mg), so it’s a very different dosing story, but the clinical outcomes for sleep looked comparable.

The comparison to cognitive behavioral therapy for insomnia (CBT-I) also comes up frequently. A small randomized pilot trial compared trazodone to CBT-I over three months and found that both improved sleep continuity, though they may affect sleep brain wave patterns differently.²³ Most sleep specialists consider CBT-I the first-line treatment for chronic insomnia, with medications like trazodone serving as adjuncts or as bridges while someone learns the behavioral techniques. If you’re on 100 mg of trazodone and sleeping better, that’s valuable, but it’s worth asking your doctor whether CBT-I might eventually let you reduce or stop the medication.

Genetic Variation and Why the Same Dose Hits People Differently

You might be on 100 mg and feel perfectly fine, while someone else on the same dose feels like they’ve been sedated for surgery. Part of this comes down to genetic variation in liver enzymes. The CYP2D6 enzyme that clears trazodone’s active metabolite mCPP varies widely across individuals. People who are poor metabolizers of CYP2D6 accumulate more mCPP, and that metabolite can cause its own set of side effects including nausea, dizziness, and increased heart rate. A pharmacogenetic study exploring this connection found that CYP2D6 status could help predict who experiences more adverse reactions on trazodone.¹⁹

This helps explain why dose recommendations are ranges rather than fixed numbers. Some people do well on 25 mg. Others genuinely need 100 mg to get the same sleep benefit. If 100 mg leaves you feeling terrible the next morning, you may be a slow metabolizer, and a lower dose or a different drug might make more sense. Pharmacogenomic testing is increasingly available but isn’t yet standard practice for trazodone prescriptions. Still, it’s something to bring up with your doctor if you’re unusually sensitive to side effects.

1
Psychopharmacology Institute. Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
2
PubMed Central. Role of trazodone in treatment of major depressive disorder: an update
3
Health Affairs Scholar. Off-label policy through the lens of trazodone usage and spending in the United States
4
PubMed Central. Trazodone for Insomnia: A Systematic Review
5
Scientific Reports. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis
6
PubMed. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials
7
PubMed Central. Trazodone enhances sleep in subjective quality but not in objective duration
8
PubMed Central. Rediscovering trazodone for the treatment of major depressive disorder
9
PubMed. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders
10
SpringerLink / Psychopharmacology. The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials
11
PubMed. Trazodone: properties and utility in multiple disorders
12
PubMed Central. Pharmacokinetics of single oral dose trazodone: a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition
13
PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension
14
American Journal of Hypertension. Orthostatic Hypotension in the Hypertensive Patient
15
PubMed. Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study
16
PubMed Central. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines
17
PubMed Central. Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study
18
PubMed. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use
19
PubMed Central. CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone An Explorative Pharmacogenetic Study
20
PubMed. Mechanisms of the development of trazodone withdrawal symptoms
21
PubMed Central. Trazodone For Sleep Disturbance After Alcohol Detoxification: A Double-Blind, Placebo-Controlled Trial
22
PubMed Central. Trazodone versus doxepin as a pharmacologic sleep aid in psychiatric inpatients: A retrospective cohort study
23
PubMed. Effect of trazodone versus cognitive-behavioural treatment on high- and slow-frequency activity during non-rapid eye movement sleep in chronic insomnia: A pilot, randomized clinical trial